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Abstract
Iodine	deficiency	during	pregnancy	and	 lactation	could	expose	 the	 infant	 to	severe	
iodine	deficiency	disorders.	A	randomized	supplementation	trial	among	rural	lactating	
women	was	conducted	in	Sidama	zone,	southern	Ethiopia,	to	compare	the	methods	of	
iodine	delivery	on	breast	milk	iodine,	and	on	maternal	and	infant	urinary	iodine	con-
centrations.	Women	were	randomly	assigned	either	to	receive	225	μg	iodine	as	potas-
sium	iodide	capsule	daily	for	6	months	or	450	g	of	appropriately	iodized	salt	(30–40	μg	I	
as	KIO3/g	of	salt)	weekly	for	household	consumption	for	6	months.	Breast	milk	iodine	
concentration	(BMIC)	and	maternal	and	infant	urinary	iodine	concentration	(UIC)	were	
measured	at	baseline	and	at	6	months.	The	women	did	not	differ	in	BMIC	and	UIC,	and	
infants	did	not	differ	in	UIC	in	a	time	by	treatment	interaction.	Median	(IQR,	interquar-
tile	range,	IQR)	BMIC	at	baseline	was	154	[43,	252]	μg/L	and	at	6	months	was	105	[36,	
198]	μg/L,	maternal	UIC	at	baseline	was	107	[71,	161]	μg/L	and	at	6	months	was	130	
[80,	208]	μg/L;	infant	UIC	at	baseline	was	218	[108,	356]	μg/L	and	at	6	months	was	
222	[117,	369]	μg/L.	Significant	correlations	among	the	three	variables	were	obtained	
in	 both	 groups	 at	 both	 times.	We	 conclude	 that	 for	 lactating	women	 an	 adequate	
amount	of	appropriately	iodized	salt	(30–40	μg	I/g)	had	similar	effects	as	a	daily	sup-
plement	of	225	μg	I	on	BMIC	and	on	maternal	and	infant	UIC.
K E Y W O R D S
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1  | INTRODUCTION
Iodine	is	required	for	the	synthesis	of	thyroid	hormones;	thyroid	hor-
mones	in	turn	regulate	the	metabolic	patterns	of	cells.	 Iodine	plays	a	
crucial	part	 in	the	process	of	early	growth	and	development	of	most	
organs,	especially	the	brain	(Chan	&	Kilby,	2000).	Severe	maternal	io-
dine	deficiency	during	early	pregnancy	could	result	in	permanent	brain	
damage	 to	 the	 offspring	 (Halpern	 et	al.,	 1991;	 Pharoah,	 Buttfield,	 &	
Hetzel,	 1971).	 Mild-	to-	moderate	 iodine	 deficiency	 may	 result	 in	 re-
duced	 learning	 ability,	 and	 increased	 risk	 of	 low	birth	weight	 and	of	
infant	morbidity	and	mortality	(Zimmermann,	2009).	Infants	under	two	
years	of	age	are	among	the	most	vulnerable	groups	to	be	affected	by	
iodine	deficiency	along	with	pregnant	 and	 lactating	mothers	 (WHO/
UNICEF	2007).	Hence,	special	attention	is	needed	for	these	population	
groups	regarding	preventing	and	controlling	iodine	deficiency	(Delange,	
2004).
Risk	 of	 iodine	 deficiency	 in	 early	 infancy	 is	 high	 even	 in	 iodine	
sufficient	 areas	 because	 infant	 intrathyroidal	 reserve	 turnover	 rate	
is	 rapid	 (Delange,	1998).	Therefore,	 in	 iodine	 insufficient	 areas,	 rec-
ommendations	for	iodine	for	women	during	pregnancy	and	lactation	
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are	 increased	 to	 250	μg/day	 or	 to	 a	 400	mg	 single	 annual	 dose	 of	
iodized	 oil	 supplement	 (Andersson,	 de	 Benoist,	 Delange,	 &	 Zupan,	
2007).	Because	a	large	amount	of	iodine	is	secreted	into	breast	milk,	
exclusively	breastfed	 infants	0–6	months	of	 age	 should	 receive	 suf-
ficient	 iodine	 through	 breast	 milk	 (Delange,	 2004;	 Spitzweg,	 Joba,	
Eisenmenger,	&	Heufelder,	1998).
Recommended	intakes	for	infants	are	based	on	mean	iodine	intake	
of	healthy	full-	term	infants	fed	breast	milk,	because	functional	criteria	
that	reflect	iodine	intake	in	infants	are	not	available.	Hence,	the	WHO	
recommends	daily	intake	of	iodine	for	infants	as	90	μg	(WHO/UNICEF/
ICCIDD	2007).	Similarly,	the	Institute	of	Medicine	(IOM)	in	the	USA	set	
the	adequate	iodine	intake	for	infants	0–6	months	of	age	at	110	μg/
day.	This	recommendation	is	based	on	two	important	points.	First,	the	
median	breast	milk	 iodine	concentration	(BMIC)	 in	the	United	States	
was	146	μg/L	(Institute	of	Medicine	2001).	Second,	based	on	the	esti-
mated	daily	breast	milk	excretion,	the	mean	amount	of	iodine	obtained	
by	an	 infant	from	0.78	L	of	human	milk	 is	approximately	115	μg/day	
(Institute	of	Medicine	2001).	 Iodine	 intake	greater	 than	 the	 require-
ment	generally	will	be	excreted	in	the	urine	(Zimmermann,	2007).
BMIC	 can	 be	 increased	 by	 increasing	 maternal	 iodine	 intake	
(Zimmermann,	2007).	In	a	study	in	16	healthy	lactating	US	women,	the	
BMIC	was	significantly	 increased	by	a	one-	time	 ingestion	of	600	μg 
potassium	 iodide	 (456	μg	of	 iodine)	with	peak	 levels	 at	6	hr	 (Leung,	
Braverman,	He,	Heeren,	&	 Pearce,	 2012).	 In	 a	 randomized,	 double-	
blind,	placebo-	controlled	study,	supplementation	to	lactating	women	
of either 75 μg/day	or	150	μg/day	of	 iodine	as	potassium	 iodate	 for	
6	months	 significantly	 increased	 the	BMIC	 and	maternal	 urinary	 io-
dine	 concentration	 (UIC).	However,	 the	 amount	of	 supplementation	
given	was	not	 sufficient	 to	 improve	 the	mothers’	or	 infants’	 thyroid	
hormones	 (Mulrine,	 Skeaff,	 Ferguson,	 Gray,	 &	Valeix,	 2010).	 In	 an-
other	double-	blind,	randomized,	placebo-	controlled	trial,	one	dose	of	
400	mg	of	 iodine	as	a	capsule	of	 iodized	poppy	seed	oil	 to	 lactating	
mothers	significantly	 increased	the	UIC	of	their	3-	month-	old	 infants	
compared	with	a	single	dose	of	100	mg	iodine	given	orally	as	an	 io-
dized	oil	supplement	directly	to	the	infants	(Bouhouch	et	al.,	2014).
As	a	strategy	to	alleviate	iodine	deficiency,	increasing	iodine	intake	
through	supplementation	or	food	fortification	has	been	recommended.	
Salt	iodization	programs	have	been	found	to	be	most	useful	because	
they	are	cost-	effective	and	feasible,	and	salt	 is	consumed	by	almost	
everyone	(WHO/UNICEF/ICCIDD	2007).	In	places	where	salt	iodiza-
tion	 is	not	 feasible	and/or	 is	unavailable,	 iodine	supplements	should	
be	given	to	at-	risk	groups	including	pregnant	or	lactating	women	and	
infants	(Andersson	et	al.,	2007).
Previous	studies	in	rural	Sidama	reported	median	UIC	of	15	μg/L	
in	pregnant	women	(Ersino,	Tadele,	Bogale,	Abuye,	&	Stoecker,	2013)	
and	37	μg/L	in	reproductive	age	women	(Gebreegziabher	et	al.,	2013).	
Our	study	was	designed	and	approved	before	Ethiopia’s	salt	iodization	
legislation	was	enacted.	Once	the	legislation	was	passed,	program	im-
plementation	was	rapid	and	the	population	began	to	have	access	to	
iodized	salt.	Thus,	our	study	with	lactating	women	compared	the	effi-
cacy	of	appropriately	iodized	household	salt	to	daily	intake	of	iodine	
capsules	in	raising	the	BMIC	and	maternal	and	infant	UIC	in	a	context	
of	villagers	already	having	some	access	to	iodized	salt.
2  | MATERIALS AND METHODS
2.1 | Data source and study population
The	 study	was	conducted	 in	 rural	 areas	of	Sidama	zone,	 southern	
Ethiopia.	 All	 lactating	 women	 (n	=	101)	 in	 the	 randomly	 selected	
study	villages	who	delivered	between	January	and	February,	2013	
were	 recruited	 within	 a	 week	 after	 delivery	 to	 participate	 in	 the	
study.	 Informed	consent	was	obtained	from	the	women	for	 them-
selves	and	for	their	infants.	This	study	was	conducted	in	accordance	
with	 the	 ethical	 principles	 for	 the	 protection	 of	 human	 subjects.	
Ethical	 approval	 was	 obtained	 from	 Oklahoma	 State	 University	
(OSU),	 USA,	 Hawassa	 University,	 Ethiopia,	 and	 the	 Ministry	 of	
Science	and	Technology,	Ethiopia.	The	study	was	a	randomized	in-
tervention	trial.
Mother-	infant	dyads	were	assigned	using	random	numbers	to	re-
ceive either 225 μg	of	iodine	as	potassium	iodide	in	capsule	form	(Pure	
Encapsulations,	Inc.	Boston,	MA)	administered	to	the	mother	daily	for	
6	months	or	450	g	(30–40	μg	of	I	as	KIO3/g	of	salt)	of	iodized	salt	(I-	
salt)	delivered	weekly	for	household	consumption	for	6	months.
Mean	 iodine	concentration	of	 the	 salt	manufactured	 for	 this	 re-
search	project	was	verified	by	inductively	coupled	plasma	mass	spec-
trophotometry	(ICP-	MS,	Elan	9000,	Perkin-	Elmer,	Norwalk,	CT)	to	be	
35.1	 (3.6)	 μg/g,	 consistent	with	 the	 recommendation	 (20–40	mg	 of	
iodine	per	kg	of	 salt)	of	 international	organizations	 (WHO/UNICEF/
ICCIDD	1996,	2007).	The	dose	of	225	μg	of	iodine	capsule	adminis-
tered	daily	was	at	the	lower	end	of	the	recommended	range	for	lactat-
ing	women	(225–350	μg	daily)	(Delange,	2007).
Capsules	were	administered	to	the	mothers	daily	by	health	exten-
sion	workers	or	salt	for	the	household	was	delivered	in	a	sealed	plastic	
bag	weekly.	The	amount	of	salt	remaining	at	the	end	of	the	first	week	
was	weighed	to	estimate	per	capita	consumption	and	the	mean	was	
10.3	 (2)	g.	Women	were	strictly	reminded	every	week	not	to	buy	or	
use	salt	 from	the	 local	market	until	 the	end	of	the	study	and	not	to	
share	 the	salt	we	gave	 them	with	anybody	outside	 their	household.	
However,	the	culture	of	valuing	and	sharing	salt	may	have	reduced	the	
amount	of	leftover	salt	reported.
2.2 | Anthropometry and questionnaire
Weight	 (kg)	and	height	 (cm)	of	mothers	were	measured	to	calculate	
body	mass	index	(BMI	=	weight	(kg)/height	(m)2).	Weight	was	meas-
ured	on	a	solar	digital	scale	(Uniscale,	UNICEF,	NY)	and	recorded	to	
the	 nearest	 100	g	 and	 height	was	measured	 to	 the	 nearest	 0.1	cm	
using	a	single	calibrated	instrument	(Adult	Board,	Schorr	Productions,	
Olney,	MD).	Mid	upper	arm	circumference	(MUAC)	was	measured	to	
the	nearest	0.1	cm	using	a	non-	stretchable	plastic	measuring	tape.	A	
pre-	tested	 questionnaire	 was	 administered	 to	 assess	 the	 socioeco-
nomic	 and	 demographic	 characteristics	 including	 household	 size	 of	
the	mothers	participating	in	the	study.
Before	 delivery	 of	 supplements,	 baseline	 data	 including	 anthro-
pometry,	urine	 samples,	breast	milk	 samples,	 and	sociodemographic	
information	were	 collected	 from	mothers.	 Infant	 urine	 samples	 also	
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were	obtained.	Following	6	months	of	supplementation,	the	same	bio-
logical	samples	were	collected	from	mothers	and	their	infants.
2.3 | Biochemical measurements
2.3.1 | Breast milk iodine
Ten	mL	 of	 breast	milk	was	 collected	 from	 each	mother	 in	 plastic	
cups	and	 stored	 in	 tightly	 capped	vials.	Breast	milk	 samples	were	
collected	between	9:00	and	11:00	AM.	Samples	were	frozen	until	
they	 are	 analyzed.	 To	 extract	 iodine	 from	 the	 breast	milk	 1.5	mL	
of	25%	tetramethylammonium	hydroxide	(TMAH)	solution	(Sigma-	
Aldrich,	St.	Louis,	MO)	and	0.5	mL	of	30%	hydrogen	peroxide	were	
added	to	the	breast	milk	samples	(3	mL)	and	mixed	well.	These	sam-
ples	were	 incubated	 in	an	oven	at	90°C	for	3	hr	using	DigiTUBES	
(Perkin-	Elmer,	 Waltham,	 MA).	 After	 cooling	 to	 room	 tempera-
ture,	 the	 samples	 were	 centrifuged	 at	 1,532	 x	 g	 for	 15	minutes.	
For	analysis,	all	breast	milk	samples	were	diluted	25-	fold	with	5%	
TMAH	 (Sigma-	Aldrich,	 St.	 Lowis,	 MO)	 in	 deionized	 water.	 BMIC	
was	analyzed	by	 ICP-	MS	(Fecher,	Goldmann,	&	Nagengast,	1998).	
Tellurium	 (Perkin-	Elmer	 Life	 and	Analytical	 Sciences,	 Shelton,	CT)	
was	utilized	as	an	internal	standard.	Non-	fat	milk	powder	(RM	1549,	
National	Institute	of	Standards	and	Technology,	Gaithersburg,	MD)	
was	used	as	an	external	control.	The	reference	value	for	the	exter-
nal	 control	 was	 3.38	±	0.02	mg	I/kg	 and	 the	measured	 value	was	
3.35	±	0.03	mg/kg.
2.4 | Urinary iodine
Mothers	provided	fresh	urine	in	a	cup	from	which	samples	were	trans-
ferred	to	vials	that	were	then	tightly	sealed.	Urine	samples	were	col-
lected	from	infants	by	placing	cotton	balls	appropriately	inside	a	plastic	
sheet	available	 in	 the	 local	market.	The	 infants	were	checked	every	
10	minutes	until	urine	was	obtained.	Urine	samples	were	collected	by	
squeezing	urine	out	of	the	cotton	balls.	New	trace	mineral	free	gloves	
were	used	for	each	infant	to	avoid	contamination.	Moreover,	samples	
of	cotton	balls	and	plastic	sheets	were	soaked	in	deionized	water	and	
the	 iodine	 content	 in	 the	water	was	 assayed.	 Iodine	 content	 in	 the	
water	was	below	the	detection	limit	of	1	μg/L.
Samples	were	 frozen	 at	 −20°C	 at	Hawassa	University	 and	 then	
transported	 to	 OSU	 for	 analysis.	 Urinary	 iodine	 was	 diluted	 in	 2%	
ammonium	hydroxide	and	analyzed	by	ICP-	MS,	with	tellurium	as	 in-
ternal	 standard	 (Caldwell	 et	al.,	 2003).	 Quality	 control	 samples	 for	
urinary	 iodine	were	measured	 every	 10	 samples	 to	 ensure	 stability	
of	the	instrument.	Urinary	creatinine	was	analyzed	using	a	BioLis	24i	
clinical	 chemistry	 analyzer	 with	 standard	 reagents	 (Carolina	 Liquid	
Chemistries	Corp.,	Brea,	CA).
2.5 | Salt and drinking water iodine concentration
A	10	g	salt	sample	was	collected	at	baseline	in	a	tightly	sealed	plastic	
bag	from	each	household	for	iodine	content	analysis.	Salt	iodine	con-
centration	(SIC)	was	analyzed	using	ICP-	MS.	A	salt	sample	(1	gm)	was	
diluted	with	2%	NH3OH	(Sigma-	Aldrich,	St.	Louis,	MO)	 in	deionized	
water	and	tellurium	was	utilized	as	an	internal	standard.
Drinking	water	 samples	were	 collected	 from	 each	 of	 the	 study	
villages.	 Water	 iodine	 concentration	 was	 analyzed	 using	 the	 same	
method	as	UIC.
2.6 | Statistical analysis
The	primary	outcome	variables	in	this	study	were	the	BMIC	and	ma-
ternal	and	infant	UIC.	All	data	were	checked	for	normality	using	the	
Kolmogorov-	Smirnov	test	and	skewed	data	were	log	transformed	be-
fore	analyses.
The	 PROC	MIXED	 command	 was	 used	 for	 linear	 mixed	 model	
analysis	to	assess	the	effect	of	the	two	methods	of	iodine	supplemen-
tation	at	6	month.	The	model	tested	treatment	(between	groups)	and	
time	(within	groups)	and	treatment	*	time	interaction.
Associations	 between	 outcome	 variables	 were	 assessed	 using	
Spearman’s	 correlation	 analysis.	The	 relation	between	multiple	vari-
ables	and	infant	UIC	were	modeled	using	stepwise	linear	regression.
Data	are	reported	as	mean	(SD),	median	with	 interquartile	range	
[IQR],	or	frequency	(%)	as	appropriate.	Significance	was	set	at	p < .05. 
SPSS	 (version	 20;	 IBM	 Corp.	 Armonk)	 and	 SAS	 (Version	 9.3;	 SAS	
Institute	Inc.,	Cary,	NC)	were	used	for	data	analyses.
3  | RESULTS
3.1 | Characteristics of study participants at baseline
All	women	breastfed	exclusively	 in	the	first	week	after	delivery	and	
continued	breast	feeding	to	6	months.	However,	only	58%	reported	
exclusive	breast	feeding	at	the	age	of	6	months	(data	not	shown).	The	
mean	(SD)	times	per	day	of	breast	feeding	in	the	24	hr	preceding	the	
survey	at	first	week	in	both	groups	was	12.8	(5.2)	(Table	1).
Mother-	infant	dyads	did	not	differ	in	any	sociodemographic	char-
acteristics	assessed	as	indicated	in	Table	1.	The	median	[IQR]	age	of	
all	mothers	was	22	 [20,	 25]	years,	mean	BMI	was	21.5	 (2.3)	 kg/m2 
and	MUAC	was	23.3	(1.7)	cm.	The	mean	gravidity	and	parity	of	all	the	
mothers	were	3	(2)	and	the	mean	household	size	was	6.0	(2.3).	Mean	
school	attendance	was	3.8	(3.5)	years.
The	median	 age	 of	 infants	 at	 baseline	was	 6	 [4,	 8]	 days.	 There	
were	50	male	and	51	female	infants	enrolled	in	the	study.	The	average	
household	salt	use	per	week	was	440	(2)	g	and	no	household	reported	
using	less	than	435.5	g	during	the	first	week.
3.2 | Breast milk and urinary iodine concentration of 
mothers and their infants
Table	2	shows	baseline	and	6	months	concentrations	and	distribu-
tions	of	BMIC	and	of	UIC	of	mothers	and	their	infants.	The	women	
were	not	 significantly	different	 in	BMIC	or	UIC	by	 treatment	 and	
the	 infants	were	 not	 significantly	 different	 in	 the	UIC	 at	 the	 two	
time	 points	 for	 either	 treatment.	 To	 better	 understand	 effects	 of	
daily	 iodine	 supplementation,	we	 categorized	BMIC	 into	different	
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groups.	At	the	end	of	the	study	at	6	months	36%	of	the	women	had	
BMIC	<	60	μg/L,	 18%	 had	 60–120	μg/L,	 29%	 had	 120–240	μg/L	
and	 16%	 had	 >240	μg/L.	 BMIC	 was	 lower	 at	 6	months	 than	 at	
baseline	but	there	was	no	significant	time	by	treatment	interaction	
(p	=	.656).
According	to	the	WHO	classification	for	iodine	deficiency	in	lac-
tating	women,	47.5%	and	38.6%	of	the	women	had	UIC	<	100	μg/L	at	
baseline	and	at	6	months,	respectively.	Furthermore,	at	baseline	11%	
of	the	women	had	UIC	below	50	μg/L	and	10%	were	below	50	μg/L	
at	6	months.	Maternal	UIC	showed	no	time	by	treatment	interaction	
(p	=	.668).	Also,	maternal	UIC	adjusted	for	creatinine	was	not	signifi-
cantly	different	between	groups	or	over	time	(p	=	.748).
The	proportion	of	infants	with	the	UIC	<	100	μg/L	at	baseline	was	
20.8%	and	at	6	months	was	15.8%.	The	median	UIC	of	 infants	was	
not	significantly	different	 in	 time	by	treatment	 interaction	 (p	=	.322)	
(Table	2).
Household	salt	iodine	concentration	collected	at	baseline	showed	
high	variation	(0–42	μg/g)	with	a	median	[IQR]	of	8.1	[4.3,	13.4]	μg/g.	
Among	 the	 salt	 samples	 tested	 21%	met	 the	minimum	 recommen-
dation	 (15	μg/g)	 (WHO/UNICEF/ICCIDD	2001)	 for	 iodine	adequacy	
(Data	not	shown).	Drinking	water	iodine	concentration	was	below	the	
detection	limit	of	1	μg/L.
Relations	between	BMIC,	maternal	UIC	and	infant	UIC	at	6	months	
were	examined	 (Data	not	shown).	BMIC	was	significantly	correlated	
with	maternal	UIC	(r	=	.39,	p	<	.001)	and	infant	UIC	(r	=	.44,	p	<	.001).	
The	correlation	between	BMIC	and	maternal	UIC	increased	when	ma-
ternal	UIC	was	adjusted	for	creatinine	(r	=	.51,	p	<	.001).	Maternal	UIC	
was	correlated	with	infant	UIC	(r	=	.31,	p	<	.001).	The	correlation	coef-
ficients	at	baseline	were	similar	to	those	at	6	months.
In	Table	3,	multiple	regression	models	with	four	best-	fitting	vari-
ables	predicting	infant	UIC	are	presented.	The	model	at	baseline	with	
all	 four	 predictors	 produced	 an	 adjusted	R2	=	.290	 and	 at	 6	months	
the	model	adjusted	R2	was	.316.	At	baseline	maternal	UIC/creatinine,	
BMIC	 and	 infant	 sex	 had	 significant	 regression	 weights,	 indicating	
infants	whose	mothers	had	higher	maternal	UIC	and	BMIC	were	ex-
pected	to	have	higher	UIC	and	female	infants	were	expected	to	have	
lower	UIC	than	males.	At	6	months	maternal	UIC/creatinine	and	BMIC	
had	significant	regression	weights,	indicating	that	higher	maternal	UIC	
Capsule group I- salt group
Mothers Baseline 6 months Baseline 6 months
BMIC	(μg/L)b 149	[46,	266] 104	[39,	197] 157	[29,	243] 111	[34,	202]
BMIC	<	120	(μg/L)c 40% 56% 39% 53%
UIC	(μg/L) 136	[76,	173] 150	[86,	220] 95	[64,	142] 110	[73,	191]
UIC	<	100	(μg/L) 42% 32% 53% 45%
I/Cre	(μg/g) 214	[142,	292] 176	[126,	383] 203	[139,	268] 173	[117,	292]
Infants
UIC	(μg/L) 234	[121,	379] 254	[130,	400] 193	[107,	331] 195	[108,	352]
UIC	<	180	μg/Ld 40% 38% 49% 47%
UIC	<	100	μg/L 16% 8% 18% 24%
aData	are	median	[IQR]	or	percentage.
bBMIC,	 breast	 milk	 iodine	 concentration;	 UIC,	 urinary	 iodine	 concentration;	 Cre,	 creatinine;	 I-	salt	
group,	iodized	salt	group.
cBMIC	≥	120	μg/L	is	assumed	to	provide	the	infant’s	daily	requirement	of	90	μg	(Zimmermann,	2007).
dInfant	UIC	≥	180	μg/L	 represents	 the	 expected	UIC	 output	 in	 the	 neonates	 and	 infants	when	 the	
recommended	dietary	 intake	of	 iodine	 (225–350	μg/day)	 for	 lactating	mothers	 and	90	μg of iodine 
daily	for	neonates	and	infants	are	met	(Delange,	2007).
TABLE  2 BMIC	and	UIC	of	mothers	and	
infants	in	subjects	who	received	iodine	as	a	
capsule	(n	=	50)	or	iodized	salt	(n	=	51)a
TABLE  1 Socio-	demographic	and	anthropometric	characteristics	
of	mother-	infant	dyads	at	baseline	(n	=	101)
Capsule 
group (n = 50)
I- Salt group 
(n = 51) p- value
Mothers
Age	(years) 23	[20,	27] 21	[20,	25] .14
MUAC	(cm) 23.2	(1.8) 23.3	(1.7) .62
BMI	(kg/m2) 21.2	(2.5) 21.8	(2.0) .15
Gravidity 2	[1.75,	4] 2	[1,	5] .41
Parity 2	[1,	4] 2	[1,	4] .38
School	years 2	[2,	3] 2	[1,	3] .42
Household	size 6	(2.6) 5.7	(2.0) .94
Frequency	of	breast	
feeding	yesterday	
(night	hours)
6.7	(2.5) 6.4	(3.1) .35
Frequency	of	breast	
feeding	yesterday	
(daylight	hours)
6.5	(2.5) 6.0	(3.1) .28
Infants
Age	(days) 5	[3,	7] 6	[5,	8] .06
Sex .765
Male 48%	(24/50) 51%	(26/51)
Female 52%	(26/50) 49%	(25/51)
Data	are	median	 [IQR],	mean	 (SD),	%	 (n/N).	Group	mean	difference	was	
analyzed	using	T-	test	or	Mann-	Whitney	U	test,	and	the	categorical	variable	
(sex)	 was	 analyzed	 using	 the	 Chi-	square	 test,	 p	<	.05	 was	 considered	
significant.
     |  925﻿GEBGG﻿GZIEBGB Iand  ﻿STGECGB
and	higher	BMIC	were	expected	to	be	associated	with	higher	 infant	
UIC.
4  | DISCUSSION
This	study	showed	BMIC,	maternal	UIC	and	infant	UIC	were	not	sig-
nificantly	different	between	mothers	who	received	225	μg of iodine 
daily	as	a	capsule	for	6	months	in	addition	to	variable	amounts	of	io-
dine	 (median	8	 [4.3,	13.4]	μg/g)	 in	 their	existing	household	salt	and	
mothers	who	received	450	g	per	household	of	appropriately	iodized	
salt	(30–40	μg/g)	delivered	weekly	for	6	months.
Average	(SD)	salt	intake	in	Ethiopia	nationally	was	estimated	at	8.4	
(5.9)	g	while	intakes	in	the	study	region	were	estimated	at	17.2	(13.8)	
g	 per	 person	 per	 day	 (Abuye,	 Berhane,	Akalu,	 Getahun,	 &	 Ersumo,	
2007).	One	reason	the	salt	intake	in	this	region	is	high	is	because	peo-
ple	in	the	rural	areas	consume	salt	in	their	coffee	several	times	a	day	in	
addition	to	other	food	items.	From	our	weekly	follow	up	however,	the	
amount	of	salt	we	provided	(450	g)	was	reported	to	be	sufficient	for	
the	household	for	1	week.	The	mean	amount	of	salt	remaining	at	the	
end	of	the	first	week	was	10.3	g.
In	the	current	study,	the	average	household	size	in	the	I-	salt	group	
was	5.7.	However,	because	one	of	the	household	members	was	a	new	
born	 infant,	who	would	 not	 be	 using	 salted	 foods,	 the	 daily	 discre-
tionary	per	capita	salt	intake	was	13.7	g	based	on	a	household	size	of	
4.7.	This	amount	of	salt	with	mean	iodine	content	of	35.1	μg/g	would	
provide	a	calculated	mean	discretionary	intake	of	481	μg	of	iodine	per	
person	per	day.	Even	with	cooking	losses	which	have	been	estimated	
at	20%,	the	iodine	intake	would	exceed	the	250	μg	daily	recommended	
for	lactating	women	(Delange,	2004,	WHO/UNICEF	2007).
Maternal	iodine	intake	is	critical	during	lactation	in	order	to	provide	
the	breastfeeding	infant’s	iodine	requirement.	Iodine	is	concentrated	
through	the	sodium	iodide	symporter	mechanism,	which	promotes	in-
creased	expression	of	 iodine	 in	milk	during	 lactation	 (Tazebay	et	al.,	
2000).	Thus,	iodine	is	present	in	breast	milk	at	higher	concentrations	
than	in	plasma	(Azizi	&	Smyth,	2009).
The	median	BMIC	(154	[43,	252]	μg/L)	at	baseline	was	within	the	
normal	range	of	150–180	μg/L	 in	 iodine	sufficient	countries	 (Dorea,	
2002;	 Semba	&	Delange,	 2001).	Despite	 iodine	 supplementation	of	
225 μg	daily	or	well-	iodized	salt	weekly	for	6	months,	median	BMIC	de-
creased	from	154	μg/L	at	baseline	to	105	[36,	198]	μg/L	at	6	months.	
Consistent	with	our	study,	although	the	baseline	iodine	status	of	the	
women	 in	New	Zealand	was	 lower,	Mulrine	et	al.	 (2010)	 found	 that	
BMIC	declined	over	 the	 first	24	weeks	 in	non-	supplemented	 lactat-
ing	women	and	supplementation	with	75	μg or 150 μg	of	iodine	daily	
did	not	increase	BMIC	to	a	level	that	could	raise	infant	median	UIC.	
In	 the	 women	 who	 received	 75	μg	 of	 iodine	 for	 24	weeks,	 BMIC	
ranged	 between	 35	 to	 57	μg/L	 and	median	 infant	UIC	was	 50	 [22,	
60]	μg/L.	 In	the	group	who	received	150	μg,	BMIC	ranged	between	
43	and	70	μg/L	and	 infant	UIC	was	66	 [36,	87]	μg/L	 (Mulrine	et	al.,	
2010).	In	another	study,	BMIC	in	non-	supplemented	mothers	declined	
from	43	μg/L	at	baseline	to	26	μg/L	over	a	9-	month-	period	while	milk	
from	the	mothers	supplemented	with	400	mg	of	iodine	declined	from	
41	μg/L	at	baseline	to	39	μg/L	at	9	months	(Bouhouch	et	al.,	2014).
It	 should	 be	 noted	 that	 our	 baseline	 data	were	 collected	within	
1	week	(with	more	than	32%	within	4	days)	after	delivery,	when	some	
colostrum	was	still	available.	Iodine	concentration	is	high	in	colostrum	
and	decreases	over	 time,	which	could	 contribute	 to	BMIC	decrease	
from	baseline	 to	6	months	 (Semba	&	Delange,	 2001).	On	 the	other	
hand,	volume	of	milk	consumed	increases	substantially	between	the	
first	days	after	birth	and	6	months	of	age,	so	the	total	amount	of	iodine	
received	by	the	infant	at	6	months	would	not	have	decreased	(Neville	
et	al.,	 1988,	WHO	1998).	However,	 because	 the	decrease	 in	 iodine	
concentration	in	breast	milk	over	time	has	not	been	measured	in	detail,	
it	 is	difficult	 to	quantify	 the	effect	our	 supplementation	had	on	 the	
usual	decrease	in	BMIC	from	colostrum	to	mature	milk.
A	 study	 conducted	 at	 a	 time	 when	 only	 4.2%	 of	 households	
in	 Ethiopia	 consumed	 iodized	 salt	 reported	 BMIC	 in	 the	 range	 of	
5–16 μg/L	 (Abuye	 &	 Kelbessa,	 2000).	 Our	 data	 collected	 after	 the	
policy	 that	 all	 salt	 should	be	 iodized	 showed	a	wide	 range	 in	BMIC	
at	 baseline	 as	 well	 as	 at	 6	months.	 At	 baseline,	 the	 BMIC	 ranged	
from 8 μg/L	to	965	μg/L	with	40%	below	120	μg/L.	At	6	months	the	
range	was	from	4	μg/L	to	958	μg/L	with	57%	below	120	μg/L.	Only	
10%	of	the	women	had	BMIC	>	300	μg/L	in	response	to	supplemen-
tation.	Although	there	was	wide	range	in	both	BMIC	and	UIC,	there	
were	few	concerningly	high	values	 in	response	to	either	 iodized	salt	
or	 iodine	 capsule	 and	 no	 adverse	 reaction	 was	 reported	 in	 any	 of	
the	study	participants.	 In	a	study	of	50	Korean	women,	whose	diets	
Variables
At baseline At 6 months
β 95% CI p β 95% CI p
Maternal	UIC/ 
Creatinine	(μg/g)
0.30 0.15,	0.64 .002 0.42 0.26,	0.65 .000
BMIC	(μg/L) 0.26 0.05,	0.29 .006 0.27 0.06,	0.28 .003
Infant’s	age	(days) −0.16 −0.05,	0.003 .083 0.12 −0.01,	0.07 .167
Female	infantb −0.18 −0.24,	−0.002 .046 −0.13 −0.19,	0.02 .121
Adjusted	R-	square 0.290 0.316
aThe	dependent	variable	(infant	UIC)	and	the	independent	variables	including	maternal	UIC/Creatinine	
and	BMIC	were	analyzed	as	log	transformed	data	because	they	were	not	normally	distributed	(n	=	101).
bInfants	sex	was	coded	as	0	for	Female	and	1	for	Male.
TABLE  3 Multiple	regression	predicting	
UIC	of	infants	at	baseline	and	6	monthsa
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frequently	included	seaweed	soup,	considerable	elevation	and	range	
of	BMIC	from	198	to	8484	μg/L	was	reported	(Rhee,	Braverman,	Pino,	
He,	&	Pearce,	2011).	Significant	variation	of	BMIC	ranging	from	5	to	
2170 μg/L	(Dorea,	2002)	and	from	9	to	1267	μg/L	(Semba	&	Delange,	
2001)	were	also	reported	in	two	other	reviews.	This	variation	indicates	
that	many	 infants	may	not	get	adequate	amounts	of	 iodine	to	meet	
their	requirement	while	others	consume	large	amounts	of	iodine	with-
out	apparent	adverse	reaction.
Maternal	median	UIC	was	not	significantly	different	between	the	
two	types	of	iodine	supplements.	Based	on	the	range	recommended	
by	Delange	(2007),	median	maternal	UIC	of	150–230	μg/L	as	an	indi-
cator	for	optimal	iodine	nutrition	during	pregnancy	and	lactation,	most	
of	our	study	participants	in	both	groups	fell	below	the	minimum	value	
at	baseline.	Following	6	months	of	iodine	supplementation,	however,	
most	of	 the	women	 in	 the	capsule	group	were	within	 the	minimum	
range	whereas	most	of	the	women	in	the	I-	salt	group	remained	below	
the	range.
For	women	in	our	study	who	had	UIC	>	100	μg/L,	which	also	has	
been	considered	adequate	for	lactating	women,	16%	at	baseline	and	
29%	at	 6	months	 had	BMIC	<	120	μg/L,	which	 is	 the	 concentration	
assumed	 adequate	 to	 cover	 the	 infant’s	 daily	 requirement	 of	 90	μg 
(Zimmermann,	2007).	For	all	women	(n	=	101)	combined	at	6	months,	
those	mothers	with	UIC	below	150	μg/L	(n	=	54)	had	median	BMIC	of	
83	μg/L	and	above	150	μg/L	(n	=	47)	median	BMIC	was	133	μg/L.	This	
could	indicate	that	iodine	intakes	of	mothers	who	had	UIC	<	150	μg/L	
were	inadequate	to	raise	iodine	status	to	a	level	that	provided	optimal	
breast	milk	iodine	for	the	infant.
The	median	maternal	UIC	of	107	μg/L	at	baseline	indicated	an	im-
provement	in	the	iodine	status	of	the	population	compared	with	prior	
years	because	Ethiopia,	including	the	study	population,	has	been	mod-
erately	to	severely	iodine	deficient	for	decades	(Median	UIC	in	stud-
ies	conducted	 in	southern	Ethiopia	between	2007	and	2010	ranged	
between	1	μg/L	 to	89	μg/L)	 (Abuye	&	Kelbessa,	 2000;	Bogale	 et	al.,	
2009;	 Ersino	 et	al.,	 2013;	 Gebreegziabher	 et	al.,	 2013;	 Girma	 et	al.,	
2012).	Therefore,	the	higher	UIC	observed	at	baseline	in	this	study	can	
be	attributed	 to	 the	salt	 iodization	program	that	began	to	be	 imple-
mented	in	2012	in	the	country	(Ethiopian	Public	Health	Institute	2014).
The	 proportion	 of	 women	with	 UIC	 below	 100	μg/L	 decreased	
from	42%	to	32%	in	the	capsule	group	and	from	53%	to	45%	in	the	
I-	salt	 group	 between	 baseline	 and	 the	 end	 of	 the	 study.	A	 double-	
blind,	 randomized,	 placebo-	controlled	 study	 in	Morocco	 reported	 a	
14%	increase	 in	UIC	at	6	months	after	giving	the	 lactating	mother	a	
400	mg	iodized	oil	capsule	(Bouhouch	et	al.,	2014).	The	study	in	New	
Zealand	showed	that	a	daily	supplement	of	either	75	μg or 150 μg of 
iodine	daily	for	6	months	during	lactation	increased	median	maternal	
UIC	significantly	but	the	median	values	still	remained	below	100	μg/L	
(Mulrine	et	al.,	2010).
In	the	current	study,	although	the	UIC	increase	was	not	significant,	
the	proportion	of	women	with	the	UIC	above	100	μg/L	was	increased	
from	58%	at	baseline	to	68%	at	6	months	 in	 the	capsule	group	and	
from	47%	at	baseline	to	55%	at	6	months	in	the	I-	salt	group.
The	recommended	dietary	intakes	(225–350	μg/day)	of	iodine	for	
lactating	mothers	and	90	μg	of	 iodine	daily	 for	neonates	and	 infants	
are	expected	 to	produce	UIC	output	 in	 the	neonates	and	 infants	of	
180–225 μg/L	(Delange,	2007).	In	the	current	study	median	UIC	of	in-
fants	was	within	the	range	of	this	expected	output	in	both	groups	and	
at	both	times.	Surprisingly	the	median	UIC	of	infants	obtained	in	this	
study	at	baseline	was	 relatively	high	 (218	μg/L)	 compared	with	data	
reported	from	three	of	four	iodine	sufficient	countries	(Zimmermann,	
2007).	 However,	 despite	 the	median	 UIC	 of	 218	μg/L	 in	 our	 study,	
17%	of	the	 infants	at	baseline	and	16%	at	6	months	had	UIC	below	
100 μg/L.
The	median	 infant	UIC	 at	 baseline	was	 significantly	 higher	 than	
BMIC	 (p	<	.001)	 and	maternal	UIC	 (p	<	.001)	 and,	 although	 not	 sig-
nificant,	median	BMIC	 tended	 to	be	higher	 than	maternal	UIC.	This	
pattern	 was	 similar	 to	 other	 studies	 that	 reported	 these	 variables	
(Bouhouch	et	al.,	2014;	Mulrine	et	al.,	2010).	The	majority	of	 iodine	
consumed	by	lactating	women	is	excreted	in	the	breast	milk;	 infants	
need	small	amounts	to	meet	their	daily	requirement,	and	the	remaining	
iodine	will	be	excreted	in	their	urine	supporting	this	pattern	(Delange,	
2007;	Zimmermann,	2007).
The	 correlation	 between	 maternal	 UIC	 and	 BMIC	 increased	
when	maternal	UIC	was	adjusted	for	creatinine.	A	study	conducted	
in	 Denmark	 likewise	 reported	 that	 urinary	 iodine	 predicted	 the	
BMIC	more	precisely	when	it	was	adjusted	for	creatinine	(Andersen,	
Moller,	&	Laurberg,	2014).	Another	study	reported	that	urinary	io-
dine	was	not	associated	with	median	thyroid	stimulating	hormone	
(TSH)	and	thyroxine	(T4)	but	was	significantly	associated	when	it	was	
adjusted	 for	 creatinine	 (Haddow,	McClain,	 Palomaki,	 &	 Hollowell,	
2007).
In	our	 regression	model	 for	 infant	UIC	at	baseline,	maternal	uri-
nary	 iodine	 adjusted	 for	 creatinine	 and	BMIC	were	 positive	 predic-
tors	and	being	female	was	a	negative	predictor.	At	6	months	maternal	
urinary	iodine	adjusted	for	creatinine	and	BMIC	were	strong	positive	
predictors.
We	 did	 not	 analyze	 iodine	 content	 of	 complementary	 foods.	
When	 complementary	 feeding	 is	 begun,	 breast	 milk	 consumption	
will	 be	 reduced	 and	 the	 amount	 of	 iodine	 provided	 to	 the	 infant	
through	breast	milk	will	decrease	(WHO	1991).	In	this	study	iodine	
concentration	of	all	of	the	water	samples	from	different	sources	was	
below	the	detection	limit	of	1	μg/L	(Data	not	shown)	predicting	low	
iodine	intake	in	the	study	area.	Because	these	subsistence	farmers	
do	 not	 buy	 foods	 from	outside,	 iodized	 salt	 is	 a	 critical	 source	 of	
iodine	 for	 the	 study	 population.	 As	 infants	 begin	 to	 get	 a	 higher	
percent	of	energy	from	low	iodine	complementary	foods,	their	total	
iodine	 intake	will	go	down.	 In	the	study	region	 (Southern	Nations,	
Nationalities	 and	 Peoples’	 Region),	 the	median	 duration	 of	 exclu-
sive	breastfeeding	was	2.2	months	 (Central	 Statistical	Agency	 and	
ICF	International	2012),	so	iodine	intake	of	infants	may	begin	to	de-
crease	early	in	life.
Unique	strengths	of	the	present	study	were	that	we	recruited	all	
of	 the	women	who	delivered	within	 the	data	 collection	 time	period	
and	compliance	was	monitored	by	daily	administration	of	capsules	and	
weekly	delivery	of	household	salt.	Unfortunately,	obtaining	approvals	
for	the	study	caused	baseline	data	collection	to	begin	after	iodized	salt	
had	begun	to	reach	the	market.
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CONCLUSIONS
In	 conclusion,	 our	 findings	 suggest	 that	 salt	 iodized	 at	 the	 recom-
mended	 level	 (30	 –	 40	μg	 I	 as	 KIO3/g)	 provided	 to	 the	 household	
had	a	similar	effect	on	BMIC	and	maternal	and	infant	UIC	as	a	daily	
supplement	of	225	μg	I	as	potassium	iodide	to	lactating	women.	The	
iodine	concentration	of	BMIC	and	UIC	obtained	in	the	study	partici-
pants	was	comparable	to	median	values	in	iodine	sufficient	countries	
(Zimmermann,	2007).
As	 a	 way	 to	 combat	 iodine	 deficiency	 disorders,	 universal	 salt	
iodization	 has	 been	 recommended.	However,	 it	 is	 important	 to	 en-
sure	that	the	salt	is	homogenously	iodized	and	contains	the	required	
amount	of	iodine.	The	salt	used	in	this	study	was	iodized	specifically	
for	research	purposes.	The	salt	sold	in	the	Ethiopian	market	at	the	time	
of	the	study	varied	notably	in	a	range	of	0–42	ppm	(data	not	shown)	
which	would	result	in	variable	iodine	intakes.
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